Stone, Richard M.
Dana-Farber Cancer Institute,
United States
2024 Rank: 11775
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 270 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 11775 | 11523 |
| Total Cites | 4693 | 5382 |
| H-index | 32 | 34 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 42 | 42 |
| Total Cites to Single Authored Papers | 7 | 7 |
| Number of Single+First Authored Papers | 74 | 74 |
| Total Cites to Single+First Authored Papers | 273 | 303 |
| Number of Single+First+Last Authored Papers | 141 | 141 |
| Total Cites to Single+First+Last Authored Papers | 472 | 520 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2952 | 3207 |
| Ratio of Total Citations to Distinct Citing Papers | 1.59 | 1.68 |
| Self-Citation Percentage |
12.80%
|
|
Stone, Richard M.
Dana-Farber Cancer Institute,
United States
2023 Rank: 11999
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 288 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 11999 | 11405 |
| Total Cites | 4229 | 4808 |
| H-index | 31 | 33 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 41 | 41 |
| Total Cites to Single Authored Papers | 9 | 9 |
| Number of Single+First Authored Papers | 72 | 72 |
| Total Cites to Single+First Authored Papers | 321 | 348 |
| Number of Single+First+Last Authored Papers | 135 | 135 |
| Total Cites to Single+First+Last Authored Papers | 513 | 561 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2709 | 2915 |
| Ratio of Total Citations to Distinct Citing Papers | 1.56 | 1.65 |
| Self-Citation Percentage |
12.04%
|
|
Stone, Richard M.
Dana-Farber Cancer Institute,
United States
2022 Rank: 7527
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 227 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 7527 | 7183 |
| Total Cites | 4511 | 5117 |
| H-index | 31 | 33 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 39 | 39 |
| Total Cites to Single Authored Papers | 17 | 17 |
| Number of Single+First Authored Papers | 70 | 70 |
| Total Cites to Single+First Authored Papers | 340 | 378 |
| Number of Single+First+Last Authored Papers | 132 | 132 |
| Total Cites to Single+First+Last Authored Papers | 560 | 625 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2769 | 2995 |
| Ratio of Total Citations to Distinct Citing Papers | 1.63 | 1.71 |
| Self-Citation Percentage |
11.84%
|
|
Stone, Richard M.
Dana-Farber Cancer Institute,
United States
2021 Rank: 7950
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 209 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 7950 | 7414 |
| Total Cites | 6539 | 7500 |
| H-index | 37 | 40 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 37 | 37 |
| Total Cites to Single Authored Papers | 22 | 24 |
| Number of Single+First Authored Papers | 69 | 69 |
| Total Cites to Single+First Authored Papers | 539 | 597 |
| Number of Single+First+Last Authored Papers | 129 | 129 |
| Total Cites to Single+First+Last Authored Papers | 818 | 912 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4110 | 4449 |
| Ratio of Total Citations to Distinct Citing Papers | 1.59 | 1.69 |
| Self-Citation Percentage |
12.81%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.